SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending due to a significant after-hours price drop following its NHS-Galleri cancer screening trial missing its primary endpoint for statistically significant late-stage cancer detection. The community is sharply divided, with many calling the market reaction an extreme overreaction given the test's perceived utility, the company's solid financials, and its ongoing FDA approval process, while others anticipate further declines and question the test's overall effectiveness.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending following a mixed market reaction to its dual financing announcement: a proposed $100 million public stock offering and a $100 million royalty funding deal with RTW Investments. While some investors express significant concern over dilution, others view the combined capital as a strategic move to secure a robust runway for its advanced pipeline and upcoming BLA submission, enhancing long-term commercialization flexibility.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending following its recent revenue growth and the significant extension of its IBSRELA and XPHOZAH patent protection into 2042, fueling community debate on long-term value creation through increased development spending versus immediate profitability, alongside continued speculation about potential strategic partnerships.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending higher after its CAGNY conference presentation emphasized strong distribution and shelf space gains, fueling community discussion around accelerated growth and intensifying speculation of a potential PepsiCo acquisition.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna (KLAR) is experiencing extreme volatility and trending heavily after its latest earnings report revealed robust revenue growth and expanding user base, especially in the US, but also a net loss driven by a significant increase in loan loss provisions. The community is sharply divided, with many calling the 'buy now, pay later' business model unsustainable and predicting further declines, while others view the sell-off as an 'overreaction' and a prime buying opportunity, citing strong underlying growth and strategic partnerships.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is trending due to its significant all-stock merger with Valaris, poised to create a dominant offshore drilling entity with a substantial backlog and anticipated cost synergies. The community is actively discussing a potential short squeeze and a long-awaited turnaround for the company amidst robust demand in the energy sector.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is generating significant buzz following recent multi-million dollar defense contracts for its Edge AI solutions, notably with the U.S. Navy's P-8A Poseidon program, and new commercial robotics business. Community discussion highlights the company's undervalued position as a pure-play in high-growth Edge AI for defense and industrial applications, alongside expectations of further major contract wins and potential short squeeze dynamics.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is seeing significant community discussion ahead of its NYSE Opening Bell ceremony, with many anticipating a short squeeze due to its small float and rising interest in the broader space sector. However, some investors are debating the company's long-term fundamentals and the direct impact of recent defense contract news.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is gaining significant attention amid strong rumors of a potential partnership with OpenAI to monetize ChatGPT through ads, fueling investor excitement and a desire for a short squeeze. This speculation comes as the community debates the stock's recent sharp decline, which many view as an unjustified overreaction to broader AI disruption fears, given the company's robust earnings and advanced AI ad-tech.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos Defense & Security Solutions is trending amidst surging defense spending expectations following proposed budget increases and escalating global tensions. The community is focused on recent substantial contract wins in hypersonics, unmanned systems, and defense testing, which, combined with bullish technical indicators, is fueling optimism for its established uptrend.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors  DelveInsight

Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with...

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the five ratings firms that are...

Equities Analysts Offer Predictions for CNTB FY2030 Earnings

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) - Equities research analysts at HC Wainwright issued their FY2030 earnings estimates for Connect Biopharma in a report...

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives Average Rating of "Moderate Buy" from Brokerages

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the five brokerages that are currently covering the...

Connect Biopharma (NASDAQ:CNTB) Shares Down 2.7% - What's Next?

Connect Biopharma (NASDAQ:CNTB) Trading Down 2.7% - What's Next...

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts

Shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) have received an average recommendation of "Moderate Buy" from the five research firms that are currently...

Connect Biopharma (NASDAQ:CNTB) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen raised shares of Connect Biopharma to a "hold" rating in a research report on Saturday...

Connect Biopharma (NASDAQ:CNTB) Now Covered by Analysts at Lake Street Capital

Lake Street Capital assumed coverage on shares of Connect Biopharma in a research report on Monday. They set a "buy" rating and a $9.00 target price for the company...

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Brokerages

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) has earned an average rating of "Moderate Buy" from the five brokerages that are presently covering the company...

Connect Biopharma Holdings Limited Sponsored ADR $CNTB Position Decreased by BML Capital Management LLC

BML Capital Management LLC reduced its holdings in Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) by 13.0% during the second quarter, according to its most recent filing...

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in San Diego, CA.

CNTB
Connect Biopharma Holdings Ltd - ADR

Feed

News

Sentiment

Fundamentals

Info

Latest CNTB News

CNTBConnect Biopharma Holdings Ltd - ADR